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Reversible phosphorylation of myosin subunits is observed in almost all eukaryotic cells. The data concern- 
ing sites and effects of phosphorylation on actin-activated ATPase activity of myosin and on its filament 
formation are described. These observations are discussed in terms of possible evolutionary trends and rules 
which may govern the process of myosin phosphorylation. 
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1. INTRODUCTION 
Actin and myosin are responsible for muscle 
contraction and seem to be involved in different 
forms of cell motility such as amoeboid move- 
ment, cytoplasmic streaming, cytokinesis or en- 
docytosis [l-3]. The structure and function of ac- 
tin were recently described in several reviews [4,5] _ 
In this article I will focus on some properties of the 
myosin molecule. The protein consists of six 
subunits: two heavy chains with a molecular mass 
about 200 kDa and two pairs of light chains with 
a molecular mass in the range 15-27 kDa (for re- 
cent reviews on myosin see [6,7]). Myosin is a 
highly asymmetric protein. Approx. 50% of the C- 
terminal parts of both heavy chains fold together 
to form a coiled-coil of cu-helices referred to as a 
tail of myosin. This region is responsible for 
assembly of myosin into bipolar filaments. The re- 
maining part of each heavy chain, together with 
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two different light chains, forms a globular head 
containing the active site of the ATPase and the 
actin-binding site. The rate of ATP hydrolysis by 
myosin is low in the presence of Mg2’, but is 
significantly enhanced upon interaction of myosin 
with actin. This actomyosin ATPase activity is an 
in vitro assay system analogous to interaction be- 
tween filaments of actin and myosin in vivo. 
The interaction of actin and myosin is controlled 
by regulatory systems which in most cases have 
been found to be calcium-sensitive (recent reviews 
[&lo]). A very widely distributed regulatory 
system is the reversible phosphorylation of myosin 
light chains and/or heavy chains (reviews [9-l 11). 
The introduction of a charged phosphate moiety 
into a myosin molecule results in marked changes 
in its a&n-activated ATPase activity and ability to 
form bipolar filaments. In the first part of the arti- 
cle the data concerning different sites and effects 
of phosphorylation on myosin properties are col- 
lated. The purpose of the present work was to 
search for order in all this complexity, and in the 
second part of the article possible evolutionary 
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trends and rules which may govern the process of 
myosin phosphorylation are presented. 
2. PHOSPHORYLATION OF MYOSIN FROM 
PROTISTA 
Myosin isolated from amoebae and slime molds 
can be phosphorylated in vivo and in vitro. The 
sites and effects of such phosphorylation are sum- 
marized in table I and some details are given below 
for each individual myosin studied. 
~cant~~~oeba myosin II (~cunt~~~oeb~ 
castellani also contains myosins IA and IB. These 
two proteins are single headed and have no tail. 
Myosins IA and IB are not discussed in the article, 
although they can be phosphorylated.), a typical 
two-headed myosin, is phosphorylated at three 
serine residues located at the end of the tail [ 12,131. 
~ephospho~lation of the heavy chains increases 
the ability of myosin II to form stable filaments 
and increases the maximum velocity of actomyosin 
ATPase activity with little, if any, effect on the af- 
finity of myosin II for actin [14,15]. Maximally 
phosphorylated myosin II has no actin-activated 
ATPase activity and forms smaller and less stable 
filaments than dephosphorylated myosin [ 15,161. 
It has been found that actin-activated ATPase ac- 
tivity and filament assembly are inhibited in 
parallel either by proteolytic removal of a region 
that contains the phospho~lation sites 1171, or by 
monoclonal antibodies specific to this region [18]. 
It has also been shown that phosphorylated 
molecules inhibit the activity of dephosphorylated 
molecules when they are contained within the same 
filament [16]. In order to explain how a catalytic 
site of the myosin head is affected by regulatory 
Table 1 
Sites and effects of phosphorylation on myosin from muscle and non-muscle 
cells 
Cell or tissue Phosphory~atab~e In vitro effects of 
subunit phosphorylation on 
Heavy Light ATPase Stability of 
chain chain activity filaments 
Acanthamoebd + - inhibition destabilization 
Dictyostelium’ + + H inhibition destabilization 
L ? ? 
Physarum + - activation stabilization 
Leukemic + + H inhibition ? 
myeIobIasts L activation 
Lymphocytes + + H ? ? 
Macrophage9 L activation 
Brain= 
Thyroid 
Platelets 
Thymus 
Smooth muscle - 
Striated muscle - 
activation stabilization 
activation stabilization 
no effectb no effect’ 
a Phosphorylation sites on the heavy chains are located at the end of the tail 
b Under certain ionic conditions a small difference in the Ann-activated 
ATPase activity of skeletal muscle myosin is observed 
’ State of phosphorylation seems to affect conformation of filaments 
H, heavy chain; L, light chain 
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sites located at the other end of a molecule the 
supramolecular mode of action of reversible 
phosphorylation was proposed [ 16,17,19]. Ac- 
cording to this hypothesis activation of actomyosin 
ATPase activity by dephosphorylation of the 
heavy chains occurs as a result of intermolecular 
interactions within the filaments and not at the 
level of a single molecule. It was therefore sug- 
gested that the phosphorylation state defines 
whether filaments of myosin II may achieve the en- 
zymatically active conformation. 
Heavy chains of myosin from Dictyostelium 
discoideum are reversibly phosphorylated in vivo 
and in vitro [20,21]. Each heavy chain has one 
phosphorylation site located at the end of the tail 
[22,23]. Dictyostefium myosin with phospho- 
rylated heavy chains has lower actin-activated AT- 
Pase activity and forms less stable filaments than 
a myosin with dephosphorylated heavy chains 
(table 1) [21]. A myosin heavy chain kinase 
isolated from D. discoideum seems to be inhibited 
by the calcium-calmodulin complex [24]. One pair 
of light chains of Dictyostelium myosin is 
phosphorylated by an endogenous kinase, but the 
effects of such phosphorylation on myosin’s prop- 
erties are not known [21]. Myosin filaments are 
present in the cortical regions of Dictyostefium 
cells 125,261. In response to a chemotactic stimulus 
the translocation of these filaments seems to occur 
in coordination with the assembly/disassembly of
the molecules [25]. A change in phosphorylation of 
myosin heavy chains was found to be induced by 
the same stimulus [27]. 
Myosin from Physarum poiycephalum plas- 
modia is phosphorylated on its heavy chains, but 
the location of the phosphorylation site is not 
known [28,29]. It was shown that unphospho- 
rylated myosin from Physarum has lower actin- 
activated ATPase activity than phosphorylated 
myosin (table 1). This is surprising, since 
phosphorylation of the heavy chains of myosin 
from Acanthamoeba, Dictyostelium and leukemic 
myeloblasts has the opposite effect on their ac- 
tomyosin ATPase activity (table 1). Filaments of 
phosphorylated myosin from Physarum are stable 
in vitro under physiological conditions, but 
filaments of unphosphorylated myosin (en- 
zymatically inactive) depolymerise to monomers 
and small oligomers with heads located at one end 
and tails on the other. 
3. PHOSPHORYLATION OF MYOSIN FROM 
NON-MUSCLE CELLS 
Two groups of vertebrate non-muscle myosins 
can be distinguished with respect to location of 
their phosphorylation sites (table 1). In the first 
group are myosins where both the light chains and 
heavy chains are phosphorylated. These are 
myosins from fibroblasts [30], macrophages 
[31-331, lymphocytes [34,35], brain tissue [36-391 
and leukemic myeloblasts [40,41]. In the second 
group are myosins where only light chains are 
phosphorylated. These include myosins from 
platelets [42], astrocytes [43], myoblasts [44], baby 
hamster kidney cells 1451, thyroid [46], thymus 
[47,48], myoepithelial cells [49], brush border 
[50,51] and adrenal medulla [52]. 
The effect of heavy chain phosphorylation on 
vertebrate non-muscle myosins is only known for 
leukemic myeloblasts: phosphorylation inhibits 
actin-activated ATPase activity of myosin from 
these cells (table 1). In myosins from brain and 
macrophages, phosphorylation sites on the heavy 
chains are located at the end of the tail [33,39], 
similar to the location of the phosphorylation sites 
of Acanthamoeba and Dictyostelium myosin. 
Regulatory light chains of myosins isolated from 
non-muscle cells are phosphorylated by a kinase 
that is activated by calmodulin. This phosphoryla- 
tion increases actin-activated ATPase activity of 
all myosins studied and affects the ability of 
myosins to assemble into filaments (table 1). 
Filaments of phosphorylated (enzymatically ac- 
tive) myosin are stable under physiological condi- 
tions, but those of unphosphorylated myosin 
depolymerise to monomers with a characteristic 
conformation [46-481. In this conformation the 
tail of the molecule is folded twice to generate 
three segments of approximately equal length. The 
sedimentation coefficient of these monomers is 
lo-12 S, whereas the sedimentation coefficient of 
monomers that are simply extended rods without 
any folds is about 6 S (such monomers are typical- 
ly observed in solutions containing higher than 
physiological salt concentrations). When folded 
monomers are phosphorylated by myosin light 
chain kinase they unfold and assemble into bipolar 
filaments [48]. 
The presence of myosin filaments in stress fibers 
of cultured cells [53] and in human glioma cells has 
been demonstrated recently [54]. 
171 
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4. PHOSPHORYLATION OF SMOOTH 
MUSCLE MYOSIN 
Muscle myosins, with the exception of 
molluscan myosin, have a pair of light chains that 
are phosphorylated by a protein kinase which is ac- 
tivated by calmodulin (reviews [g-11]). There are 
no confirmed reports of myosin heavy chain 
phosphorylation in muscle. Much of the informa- 
tion regarding the effects of light chain 
phosphorylation has been obtained from studies of 
myosin from smooth muscle. Evidence from many 
experiments, in vivo and in vitro, indicates that 
phosphorylation of myosin plays a primary role in 
regulation of the contraction-relaxation cycle of 
smooth muscle (reviews [55,56]). It has been 
shown that contraction does not occur in the 
absence of phosphorylation, and that 
phosphorylation precedes tension development. It 
also appears that phosphorylation regulates the 
cross-bridge cycling rate. However, all these 
physiologically oriented studies indiogte that 
phosphorylation alone may not be adequate to ac- 
count fully for all the experimental observations 
and it is evident that other factors are implicated 
(reviews [57,58]). 
It has been established that phosphorylated 
smooth muscle myosin exhibits high actin- 
activated ATPase activity in vitro whereas un- 
phosphorylated myosin exhibits low activity 
[59,60]. The relationship between the extent of 
light chain phosphorylation and actomyosin 
ATPase activity depends on the aggregation state 
of myosin which may indicate that reactivity of 
myosin heads is different in filaments than in 
monomers [61-631. Phosphorylation of regulatory 
light chains of smooth muscle heavy meromyosin 
(a soluble proteolytic fragment of myosin) 
regulates its actin-activated ATPase activity 
similarly to that of undigested myosin. 
Phosphorylated smooth muscle myosin has higher 
affinity for actin than unphosphorylated myosin, 
but the difference is too small to explain the dif- 
ference in their maximal rates of ATP hydrolysis 
[64]. It was therefore suggested that light chain 
phosphorylation regulates some steps in the ATP 
hydrolysis cycle and that unphosphorylated light 
chain does not cause a steric blocking between ac- 
tin and myosin [64]. The phosphorylation state of 
smooth muscle myosin influences its ability to 
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assemble into bipolar filaments in vitro 
[48,65-681. At physiological salt concentrations 
and in the presence of ATP only phosphorylated 
myosin is filamentous, and unphosphorylated 
myosin exists as a 10 S monomer. This 10 S con- 
formation is identical to the folded conformation 
described for myosin from non-muscle cells [48]. 
As a consequence of folding and intramolecular in- 
teraction a 10 S molecule is unable to polymerize 
and has lower ATPase activities than myosin in the 
6 S conformation [69]. Phosphorylation of 10 S 
monomers by myosin light chain kinase induces 
unfolding of tails and assembly of formed 6 S 
monomers into stable bipolar filaments [48]. There 
is no indication that the 10 S monomer exists in 
smooth muscle in situ. In contrast, it has been 
shown that myosin is filamentous even in relaxing 
smooth muscle [70,71]. It is possible that the 10 S 
conformation can be mimicked by intermolecular 
interactions between the hinge region of one 
myosin molecule and the tail of another in the 
same filament and that it generates analogous 
changes in the reactivity of myosin heads. 
Phosphorylatian of myosin light chains also 
takes place in skeletal and cardiac muscle, 
although its function appears to be markedly dif- 
ferent from that in smooth muscle (reviews 
[3,8-l 11). The contraction-relaxation cycle of 
striated muscle is regulated by the Ca2+-sensitive 
complex of troponin and tropomyosin. However, 
some evidence indicates that light chain 
phosphorylation acts as a secondary mechanism of 
regulation in these muscles. Actin-activated 
ATPase activity of striated muscle myosin does not 
depend on the state of phosphorylation in vitro. 
Unphosphorylated as well as phosphorylated 
forms exhibit high actomyosin ATPase activity 
and form stable filaments. 
The information regarding phosphorylation of 
myosin from muscle of invertebrates is very 
limited. Actin-activated ATPase activity of myosin 
from Limulus increases when the light chains are 
phosphorylated by an endogenous kinase. The 
kinase is activated by calmodulin [72]. 
The striated muscle of scallop represents an ex- 
ample of a myosin that cannot be phosphorylated 
[73], but smooth muscle myosin from scallop 
seems to be phosphorylated, like other myosins 
1741. 
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5. POSSIBLE RULES AND EVOLUTIONARY 
TRENDS OF MYOSIN 
PHOSPHORYLATION 
On the basis of the data presented above the ef- 
fects of myosin phosphorylation are discussed in 
terms of possible rules and evolutionary trends. 
(1) Reversible phosphorylation of myosin 
subunits seems to occur in all eukaryotic cells ex- 
cept striated muscle of some mollusca. In amoebae 
and slime molds the main subunit that is 
phosphorylated is a myosin heavy chain. On the 
other hand, in muscle and some vertebrate non- 
muscle cells only the light chains are 
phosphorylated. The change of location of the 
phosphorylation sites seems to be one of the major 
evolutionary events during specialization of 
regulatory mechanisms of contraction and motili- 
ty. If this is true, non-muscle cells in which 
phosphorylation of both light chains and heavy 
chains is observed may represent he transitional 
step of these evolutionary changes. There is no 
direct evidence that such cells contain one type of 
myosin which is phosphorylated in two different 
ways. It is possible that these cells contain two 
myosin isoenzymes: one phosphorylated on the 
heavy chains and another phosphorylated on the 
light chains. 
(2) Regulatory light chains of muscle and non- 
muscle myosins are phosphorylated by a specific 
protein kinase which is activated by 
Ca2+-calmodulin. Heavy chains of myosin from 
Dictyostelium seem to be phosphorylated by a 
kinase that is inhibited by Ca’+-calmodulin. It may 
be speculated that the heavy chain kinases respon- 
sible for inactivation of other myosins are also in- 
hibited by calmodulin. 
(3) Regulatory light chains of muscle myosins 
are located near the hinge region between the heads 
and the tails. It is likely that phosphorylatable light 
chains of non-muscle myosins have a similar loca- 
tion. Phosphorylation sites on the heavy chains of 
four myosins tested so far are located at the end of 
the myosin tail (table 1). It is probable that 
phosphorylation sites on the heavy chains of the 
other myosins are located at the homologous 
position. 
(4) Actin-activated ATPase activity of smooth 
muscle and non-muscle myosins is regulated by the 
state of phosphorylation of either heavy chains 
and/or light chains. Phosphorylation of the light 
chains stimulates the actomyosin ATPase activity 
of all myosins tested. Phosphorylation of the 
heavy chains inhibits actomyosin ATPase activity 
in all cases except one. If light chains and heavy 
chains of the same myosin molecule are 
phosphorylated, then it would be reasonable to ex- 
pect that only one of four forms of such a myosin 
will be enzymatically active, as shown by leukemic 
myeloblast myosin. 
(5) The level of myosin phosphorylation seems 
to affect the V,, of the ATPase to a greater extent 
than the affinity of myosin for actin. This may in- 
dicate that regulation by reversible phosphoryla- 
tion operates according to the kinetic model and 
not the steric blocking model. The new informa- 
tion suggests that other regulatory systems, such as 
troponin-tropomyosin in striated muscle [75] and 
Ca” binding to myosin from muscle of scallop 
also seem to operate according to the kinetic model 
[76]. It may be speculated, therefore, that the basic 
mechanisms of ATP hydrolysis by myosin and ac- 
tomyosin have not changed during evolution and 
that all regulatory systems have had to adjust to 
these mechanisms. 
(6) It appears that the state of phosphorylation 
of heavy chains or light chains defines polymeris- 
ing properties of myosin in vitro in such a way that 
only one species forms stable filaments in the 
presence of ATP and at physiological salt concen- 
trations. Different stabilities of myosin filaments 
may reflect changes in intramolecular and inter- 
molecular interactions within these structures. 
Dephosphorylation of light chains induces folding 
of myosin tails and consequently either 
depolymerises existing filaments or inhibits their 
formation. Folding of myosin tails has also been 
observed for myosins with phosphorylatable heavy 
chains, e.g. Phywum myosin. However, the 
mechanisms of regulation of filament assembly 
seem to be different from those that occur after 
light chain phosphorylation. The following obser- 
vations indicate that heavy chain phosphorylation 
may inhibit primarily formation of antiparallel 
dimers. First, the phosphorylatable sites are 
located within the regions which take part in dimer 
formation. Second, the example of Physwum 
myosin which forms only one-polar oligomer in 
the dephosphorylated form and bipolar filaments 
in the phosphorylated form. Third, the example of 
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Acanthamoeba myosin II, which after proteolytic 
removal of the regulatory sites is unable to 
polymerise and forms only monomers and one- 
polar dimer . 
(7) Two properties of myosin, actin-activated 
ATPase activity and stability of filaments, appear 
to be tightly coupled in vitro. Myosins from 
amoebae and slime molds form stable filaments in 
a form which has higher actomyosin ATPase ac- 
tivity (dephosphorylated heavy chains of Acan- 
thamoeba and Dictyostelium myosin and 
phosphorylated heavy chains of Physarum 
myosin). Similarly, smooth muscle and non- 
muscle myosins form stable filaments when their 
light chains are phosphorylated, i.e. when their 
ATPase activity is actin-activatable. It appears, as 
postulated earlier by other authors, that only 
myosin forms which have high ATPase activity 
form stable filaments in vitro, irrespective of their 
origin. 
(8) The coupling rule is not always supported 
when studies are carried out in vivo. For instance, 
actin-activated ATPase activity and filament for- 
mation of smooth muscle myosin are coupled only 
in vitro and not in vivo. This observation may be 
explained in at least two ways. One possibility is 
that interaction of dephosphorylated myosin with 
actin filaments stabilizes smooth muscle thick 
filaments. Another is that a hypothetical protein 
keeps filaments assembled in situ after myosin 
dephosphorylation. 
Evidence from studies in vivo suggests that the 
transient assembly and disassembly of myosin 
filaments takes place in amoebae. It may be sug- 
gested therefore that in primitive motile systems 
the coupling of actomyosin ATPase activity and 
filament formation via heavy chain phosphoryla- 
tion does exist. Whether the similar mode of action 
via light chain phosphorylation may operate in 
non-muscle cells in vivo remains to be established. 
(9) The data from experiments in vitro may in- 
dicate that phosphorylation has a dual effect on 
myosin. The primary effect seems to be a regula- 
tion of myosin polymerisation. Assembly of 
bipolar filaments brings together a large number of 
ordered myosin heads into the proximity of actin 
filaments, which is important for efficient motility 
and contraction. It may be suggested that this 
primary effect of phosphorylation operates in the 
motile systems in which a transient assembly of 
myosin takes place. 
174 
Secondary effects of phosphorylation are 
probably based on the intermolecular and in- 
tramolecular interactions within the filaments be- 
tween phosphorylation sites and hinge regions. 
The interactions define the conformation of 
myosin filaments and hence the level of actin- 
activated ATPase activity. The nature of the active 
or inactive configuration is not known in 
molecular detail, but is likely to involve different 
orientations and flexibility of myosin heads. In the 
case of heavy chain phosphorylation interaction 
between the hinge region and phosphorylation sites 
of aggregated myosin may take place only among 
different molecules. Therefore, maximal ac- 
tomyosin ATPase activity is observed when 
myosin is filamentous, as shown for instance by 
Acanthamoeba myosin II. In the case of light 
chain phosphorylation interaction between 
regulatory sites and the hinge region may take 
place in two distinct ways: intramolecularly and in- 
termolecularly. In the filaments, both types of in- 
teraction may occur and both may have relevance 
in situ. Intramolecular interactions seem to be suf- 
ficient in vitro for regulation of the soluble myosin 
fragments that contain a hinge region. 
6. CONCLUSIONS 
The rules which may govern the process of 
myosin phosphorylation in smooth muscle and 
non-muscle cells can be summarized in the form of 
the following hypothesis. During specialization of 
motile systems a change in location of 
phosphorylation sites took place: in the more 
primitive motile systems the regulatory sites are 
located on the heavy chains and in the more 
specialized systems on the light chains. It may be 
suggested that the change did not alter three major 
features of myosin phosphorylation. 
First, Ca2+ regulation mediated by calmodulin 
remained, i.e. not only the light chain kinases, but 
also the heavy chain kinases are calmodulin- 
dependent. 
Second, a role of phosphorylation in regulation 
of myosin contractile activity was preserved. 
Third, a dual mode of action of phosphorylation 
was maintained. The state of phosphorylation 
regulates myosin assembly and, through interac- 
tions within the filaments, reactivity of myosin 
heads. 
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